Actively Recruiting

Age: 20Years - 45Years
FEMALE
ID06163092

The Prevalence of Chronic Endometritis and Therapeutic Benefits of Antibiotics in Women With Unexplained Recurrent Miscarriage

Led by Chinese University of Hong Kong · Updated on 2025-03-20

175

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to determine how often chronic endometritis (CE) occurs in women with unexplained recurrent miscarriage and to study the types of microorganisms involved in CE. It also investigates whether antibiotic treatments can help women who have CE and a history of multiple miscarriages. The study is observational and focuses on women aged 20 to 45 years with two or more consecutive miscarriages before 24 weeks of pregnancy. Women who join the study will undergo endometrial sampling during the mid-luteal phase, timed precisely seven days after their luteinizing hormone (LH) surge, detected by daily urine tests. The sample is collected using a Pipelle sampler during an outpatient visit. The tissue is analyzed for plasma cells, stromal cell changes, and infectious agents through microscopic and microbial tests. If CE is diagnosed, antibiotics are prescribed based on the infection type or given empirically, with treatment repeated up to three times if necessary. Participants will have repeat endometrial biopsies after antibiotic treatment to check for CE persistence. Researchers will monitor the incidence of CE, identify the microorganisms present, and compare pregnancy outcomes between women cured of CE and those without CE. The study involves outpatient procedures, laboratory tests, and clinical follow-ups, continuing until January 2027 to assess the therapeutic effects and pregnancy outcomes.

CONDITIONS

Brief Title

Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage

Who Can Participate

Age: 20Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation
  • Women aged 20 to 45 years old
Not Eligible

You will not qualify if you...

  • Uncorrected uterine anomalies, such as septate or bicornuate uterus, fibroids (submucous/intramural)
  • Untreated hydrosalpinx
  • Antiphospholipid syndrome
  • Known clinical autoimmune disease
  • Undergoing immunotherapy
  • Abnormal thyroid function
  • Abnormal karyotyping of couples
  • Known immunodeficiency pathologies such as diabetes or HIV
  • Currently taking other antibiotics or other trial medications or traditional Chinese medicine
  • Currently or previously involved in other clinical trials with medication intake
  • Those with active pelvic inflammatory disease or suspicion of infection etc.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for eligibility assessment

Diagnostic Evaluation

Duration - 1 menstrual cycle

Participants undergo endometrial sampling (ES) using a Pipelle sampler as an outpatient procedure to diagnose chronic endometritis.

1 outpatient visit for endometrial sampling precisely 7 days after LH surge

Treatment

Duration - Up to 3 courses of 14 days each

Participants diagnosed with chronic endometritis receive antibiotic treatment based on microbial culture results or empirical therapy with doxycycline. Endometrial biopsy will be repeated after antibiotic treatment to assess cure. Additional antibiotic courses may be given if CE persists, up to three courses depending on participant willingness.

1 to 4 outpatient visits for antibiotic treatment and repeated biopsies depending on response

Long-term Monitoring

Duration - Up to 1 year

Participants are observed for pregnancy outcomes and resolution of chronic endometritis after treatment.

Follow-up visits as per routine clinical care

Trial Site Locations

Total: 1 location

1

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

S

Stacey Wong, BSc

J

Jacqueline Pui Wah Chung, MBBS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Is Plasma Level of Mannose Binding Lectin Associated With Re...

Mannose-Binding Lectin Deficiency

Actively Recruiting

1 location

Effect of Prednisolone Treatment on Uterine Natural Killer C...

Recurrent Miscarriage

Actively Recruiting

1 location

Analysis of Immune Cell Populations in the Endometrium and P...

Infertility, Female

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here